Norharmane prevents muscle aging via activation of SKN-1/NRF2 stress response pathways

Sarcopenia, the age-related decline in muscle mass and function, is a significant contributor to increased frailty and mortality in the elderly. Currently, no FDA-approved treatment exists for sarcopenia. Here, we identified norharmane (NR), a β-carboline alkaloid, as a potential therapeutic agent f...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Farida S. Nirmala, Hyunjung Lee, Yejin Cho, Min Young Um, Hyo Deok Seo, Chang Hwa Jung, Jeong-Hoon Hahm, Jiyun Ahn
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Elsevier 2025-03-01
Cyfres:	Redox Biology
Pynciau:	Sarcopenia Norharmane Nrf2 SKN-1 Myogenesis Mitochondrial function
Mynediad Ar-lein:	http://www.sciencedirect.com/science/article/pii/S2213231725000254
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!